This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Consider key factors when choosing expense tracking software, including compatibility, features, and security. Make an informed decision with our step-by-step guide.
20,557 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
As Xeris prepares to unpack its Q1 2026 results, investors want clarity on revenue, cash runway, and pipeline milesto...
Midweek is a prime time to refresh your investment plan. This Wednesday Reads guide breaks down tax-smart moves, mark...
Crispr Therapeutics Stock Absurdly Cheap signals a rare biotech bargain. Learn what could drive a 437% upside, the ca...
Nu Holdings stands at a pivotal moment in 2026. This piece breaks down three catalysts that could send Nu stock soari...
The week brought a roughly 10% drop for Xanadu Quantum Technologies stock as market enthusiasm cools and insiders tra...
In June, SMCI faced a sharp 36% slide as investors weighed dilution, changing AI demand tides, and macro uncertainty....
Archer Aviation sparked a strong intraday move after revealing Thunder, a hybrid VTOL platform developed with Anduril...
Yield-focused investors have chased AMDY's eye-catching yield this options strategy promises. Yet the income is volat...
Nebius Group stock charged higher on Wednesday amid fresh AI cloud developments. This article breaks down the catalys...
Insider stock moves can be routine or signaling. This article breaks down the facts behind ford's farley sells 6,454,...
Sui Group's Q1 2026 results shed light on the company’s momentum and future path. This analysis breaks down the numbe...